Impact of selected inborn errors of metabolism on prenatal and neonatal development

IUBMB Life

Volumn 62, Issue 6, 2010, Pages 403-413

  Illsinger, Sabine ^a   Das, Anibh M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fatty acid oxidation; Fetus; Galactosemia; Maternal PKU; Maturation; Metabolism; Mitochondria; Morbus niemann pick type C; Neonatal period; Pyruvate dehydrogenase; Respiratory chain; Urea cycle disorder

Indexed keywords

CARBOHYDRATE; MIGLUSTAT;

AMINO ACID METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FETUS DEVELOPMENT; FETUS MATURITY; GALACTOSEMIA; GENE EXPRESSION; HUMAN; INBORN ERROR OF METABOLISM; LYSOSOME; METABOLIC DISORDER; NEWBORN PERIOD; NIEMANN PICK DISEASE; PATHOPHYSIOLOGY; PERINATAL DEVELOPMENT; PHENYLKETONURIA; PRENATAL DEVELOPMENT; PRENATAL GROWTH; REVIEW;

FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 77953581934     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.336     Document Type: Review

References (99)

1. Nissenkorn, A., Michelson, M., Ben-Zeev, B., and Lerman-Sagie, T. (2001) Inborn errors of metabolism: a cause of abnormal brain development. Neurology 56, 1265-1272.
2. Prasad, A. N., Malinger, G., and Lerman-Sagie, T. (2009) Primary disorders of metabolism and disturbed fetal brain development. Clin. Perinatol. 36, 621-638.
3. Gluckman, P. D. and Hanson, M. A. (2004) Living with the past: evolution, development, and patterns of disease. Science 305, 1733-1736.
4. Wilson, J. M. G. and Jungner, G. (1968) Principles and practice of Screening for Disease. Public Health Papers Geneva World Health Organization 34, 156.
5. Das, A. M., Illsinger, S., Hartmann, H., Oehler, K., Bohnhorst, B., Kuhn-Velten, W. N., and Lucke, T. (2009) Prenatal benzoate treatment in urea cycle defects. Arch. Dis. Child Fetal Neonatal Ed. 94, F216-217.
6. Shin-Buehring, Y. S., Beier, T., Tan, A., Osang, M., and Schaub, J. (1977) The activity of galactose-1-phosphate uridyltransferase and galactokinase in human fetal organs. Pediatr. Res. 11, 1045-1051.
7. Ballard, F. J. and Oliver, I. T. (1965) Carbohydrate Metabolism in Liver from Foetal and Neonatal Sheep. Biochem. J. 95, 191-200.
8. Allen, J. T., Gillett, M., Holton, J. B., King, G. S., and Pettit, B. R. (1980) Evidence for galactosaemia in utero. Lancet 1, 603.
9. Kliegman, R. M. and Sparks, J. W. (1985) Perinatal galactose metabolism. J. Pediatr. 107, 831-841.
10. Litchfield, W. J. and Wells, W. W. (1978) Effect of galactose on free radical reactions of polymorphonuclear leukocytes. Arch. Biochem. Biophys. 188, 26-30.
11. Huttenlocher, P. R., Hillman, R. E., and Hsia, Y. E. (1970) Pseudotumor cerebri in galactosemia. J. Pediatr. 76, 902-905.
12. Ning, C., Reynolds, R., Chen, J., Yager, C., Berry, G. T., McNamara, P. D., Leslie, N., and Segal, S. (2000) Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr. Res. 48, 211-217. (Pubitemid 30497339)
13. Stambolian, D. (1988) Galactose and cataract. Surv. Ophthalmol. 32, 333-349.
14. Shin-Buehring, Y. S. and Schaub, J. (1980) Pitfalls in the radioactive method of galactose-1-phosphate uridyltransferase activity measurement. Clin. Chim. Acta. 106, 231-234.
15. Horslen, S. P., McCowan, T. C., Goertzen, T. C., Warkentin, P. I., Cai, H. B., Strom, S. C., and Fox, I. J. (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111, 1262-1267.
16. Meyburg, J., Das, A. M., Hoerster, F., Lindner, M., Kriegbaum, H., Engelmann, G., Schmidt, J., Ott, M., Pettenazzo, A., Luecke, T., Bertram, H., Hoffmann, G. F., and Burlina, A. (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87, 636-641.
17. Koch, R., Hanley, W., Levy, H., Matalon, K., Matalon, R., Rouse, B., Trefz, F., Guttler, F., Azen, C., Platt, L., Waisbren, S., Widaman, K., Ning, J., Friedman, E. G., and de la Cruz, F. (2003) The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics 112, 1523-1529.
18. Feillet, F., Abadie, V., Berthelot, J., Maurin, N., Ogier, H., Vidailhet, M., Farriaux, J. P., and de Parscau, L. (2004) Maternal phenylketonuria: the French survey. Eur. J. Pediatr. 163, 540-546.
19. Lee, P. J., Ridout, D., Walter, J. H., and Cockburn, F. (2005) Maternal phenylketonuria: report from the United Kingdom Registry 1978-97. Arch. Dis. Child. 90, 143-146.
20. Levy, H. L., Lobbregt, D., Platt, L. D., and Benacerraf, B. R. (1996) Fetal ultrasonography in maternal PKU. Prenat. Diagn. 16, 599-604.
21. Levy, H. L., Guldberg, P., Guttler, F., Hanley, W. B., Matalon, R., Rouse, B. M., Trefz, F., Azen, C., Allred, E. N., de la Cruz, F., and Koch, R. (2001) Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr. Res. 49, 636-642.
22. Levy, H. L., Lobbregt, D., Barnes, P. D., and Poussaint, T. Y. (1996) Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring. J. Pediatr. 128, 770-775.
23. Lenke, R. R., and Levy, H. L. (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med. 303, 1202-1208.
24. Guttler, F., Azen, C., Guldberg, P., Romstad, A., Hanley, W. B., Levy, H. L., Matalon, R., Rouse, B. M., Trefz, F., de la Cruz, F., and Koch, R. (2003) Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome. Pediatrics 112, 1530-1533.
25. Kudo, Y. and Boyd, C. A. (1990) Transport of amino acids by the human placenta: predicted effects thereon of maternal hyperphenylalaninaemia. J. Inherit. Metab. Dis. 13, 617-626.
26. Levy, H. L. and Ghavami, M. (1996) Maternal phenylketonuria: a metabolic teratogen. Teratology 53, 176-184.
27. Denno, K. M. and Sadler, T. W. (1990) Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture. Teratology 42, 565-570.
28. Loo, Y. H., Rabe, A., Potempska, A., Wang, P., Fersko, R., and Wisniewski, H. M. (1983) Experimental maternal phenylketonuria: an examination of two animal models. Dev. Neurosci. 6, 227-234.
29. Kure, S., Hou, D. C., Ohura, T., Iwamoto, H., Suzuki, S., Sugiyama, N., Sakamoto, O., Fujii, K., Matsubara, Y., and Narisawa, K. (1999) Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 135, 375-378.
30. Trefz, F. K. and Blau, N. (2003) Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria. Pediatrics 112, 1566-1569.
31. Vanier, M. T. and Millat, G. (2003) Niemann-Pick disease type C. Clin. Genet. 64, 269-281.
32. Meikle, P. J., Hopwood, J. J., Clague, A. E., and Carey, W. F. (1999) Prevalence of lysosomal storage disorders. JAMA 281, 249-254.
33. Pinto, R., Caseiro, C., Lemos, M., Lopes, L., Fontes, A., Ribeiro, H., Pinto, E., Silva, E., Rocha, S., Marcao, A., Ribeiro, I., Lacerda, L., Ribeiro, G., Amaral, O., and Sa Miranda, M. C. (2004) Prevalence of lysosomal storage diseases in Portugal. Eur. J. Hum. Genet. 12, 87-92.
34. Wraith, J. E., Baumgartner, M. R., Bembi, B., Covanis, A., Levade, T., Mengel, E., Pineda, M., Sedel, F., Topcu, M., Vanier, M. T., Widner, H., Wijburg, F. A., and Patterson, M. C. (2009) Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol. Genet. Metab. 98, 152-165.
35. Pacheco, C. D. and Lieberman, A. P. (2008) The pathogenesis of Niemann- Pick type C disease: a role for autophagy? Expert Rev. Mol. Med. 10, e26.
36. Yu, W., Gong, J. S., Ko, M., Garver, W. S., Yanagisawa, K., and Michikawa, M. (2005) Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem. 280, 11731-11739.
37. Rimkunas, V. M., Graham, M. J., Crooke, R. M., and Liscum, L. (2009) TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann- Pick type C liver disease. J. Lipid Res. 50, 327-333.
38. Maconochie, I. K., Chong, S., Mieli-Vergani, G., Lake, B. D., and Mowat, A. P. (1989) Fetal ascites: an unusual presentation of Niemann- Pick disease type C. Arch. Dis. Child. 64, 1391-1393.
39. Manning, D. J., Price, W. I., and Pearse, R. G. (1990) Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch. Dis. Child. 65, 335-336.
40. Spiegel, R., Raas-Rothschild, A., Reish, O., Regev, M., Meiner, V., Bargal, R., Sury, V., Meir, K., Nadjari, M., Hermann, G., Iancu, T. C., Shalev, S. A., and Zeigler, M. (2009) The clinical spectrum of fetal Niemann-Pick type C. Am. J. Med. Genet. A 149A, 446-450.
41. Garver, W. S., Francis, G. A., Jelinek, D., Shepherd, G., Flynn, J., Castro, G., Walsh Vockley, C., Coppock, D. L., Pettit, K. M., Heidenreich, R. A., and Meaney, F. J. (2007) The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am. J. Med. Genet. A 143A, 1204-1211.
42. Imrie, J., Dasgupta, S., Besley, G. T., Harris, C., Heptinstall, L., Knight, S., Vanier, M. T., Fensom, A. H., Ward, C., Jacklin, E., Whitehouse, C., and Wraith, J. E. (2007) The natural history of Niemann-Pick disease type C in the UK. J. Inherit. Metab. Dis. 30, 51-59.
43. Ries, M., Schaefer, E., Luhrs, T., Mani, L., Kuhn, J., Vanier, M. T., Krummenauer, F., Gal, A., Beck, M., and Mengel, E. (2006) Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C. J. Inherit. Metab. Dis. 29, 647-652.
44. Boot, R. G., Renkema, G. H., Verhoek, M., Strijland, A., Bliek, J., de Meulemeester, T. M., Mannens, M. M., and Aerts, J. M. (1998) The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem. 273, 25680-25685.
45. Vanier, M. T., Rodriguez-Lafrasse, C., Rousson, R., Mandon, G., Boue, J., Choiset, A., Peyrat, M. F., Dumontel, C., Juge, M. C., Pentchev, P. G., Revol, A., and Lomisot, P. (1992) Prenatal diagnosis of Niemann- Pick type C disease: current strategy from an experience of 37 pregnancies at risk. Am. J. Hum. Genet. 51, 111-122.
46. Vanier, M. T. (2002) Prenatal diagnosis of Niemann-Pick diseases types A, B and C. Prenat. Diagn. 22, 630-632.
47. Millat, G., Chikh, K., Naureckiene, S., Sleat, D. E., Fensom, A. H., Higaki, K., Elleder, M., Lobel, P., and Vanier, M. T. (2001) Niemann- Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am. J. Hum. Genet. 69, 1013-1021.
48. Tsukamoto, H., Yamamoto, T., Nishigaki, T., Sakai, N., Nanba, E., Ninomiya, H., Ohno, K., Inui, K., and Okada, S. (2001) SSCP analysis by RT-PCR for the prenatal diagnosis of Niemann-Pick disease type C. Prenat. Diagn. 21, 55-57.
49. Zervas, M., Somers, K. L., Thrall, M. A., and Walkley, S. U. (2001) Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr. Biol. 11, 1283-1287.
50. Patterson, M. C., Vecchio, D., Prady, H., Abel, L., and Wraith, J. E. (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 6, 765-772.
51. Patterson, M. C., Vecchio, D., Jacklin, E., Abel, L., Chadha-Boreham, H., Luzy, C., Giorgino, R., and Wraith, J. E. (2010) Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C. J. Child Neurol. 25, 300-305.
52. Shekhawat, P., Bennett, M. J., Sadovsky, Y., Nelson, D. M., Rakheja, D., and Strauss, A. W. (2003) Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am. J. Physiol. Endocrinol. Metab. 284, E1098-E1105.
53. Rakheja, D., Bennett, M. J., Foster, B. M., Domiati-Saad, R., and Rogers, B. B. (2002) Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 23, 447-450.
54. Oey, N. A., den Boer, M. E., Ruiter, J. P., Wanders, R. J., Duran, M., Waterham, H. R., Boer, K., van der Post, J. A., and Wijburg, F. A. (2003) High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J. Inherit. Metab. Dis. 26, 385-392.
55. Oey, N. A., den Boer, M. E., Wijburg, F. A., Vekemans, M., Auge, J., Steiner, C., Wanders, R. J., Waterham, H. R., Ruiter, J. P., and Attie-Bitach, T. (2005) Long-chain fatty acid oxidation during early human development. Pediatr. Res. 57, 755-759.
56. Oey, N. A., Ruiter, J. P., Attie-Bitach, T., Ijlst, L., Wanders, R. J., and Wijburg, F. A. (2006) Fatty acid oxidation in the human fetus: implications for fetal and adult disease. J. Inherit. Metab. Dis. 29, 71-75.
57. Prieur, B., Cordeau-Lossouarn, L., Rotig, A., Bismuth, J., Geloso, J. P., and Delaval, E. (1995) Perinatal maturation of rat kidney mitochondria. Biochem. J. 305(Pt. 2), 675-680.
58. Faivre, L., Cormier-Daire, V., Chretien, D., Christoph von Kleist- Retzow, J., Amiel, J., Dommergues, M., Saudubray, J. M., Dumez, Y., Rotig, A., Rustin, P., and Munnich, A. (2000) Determination of enzyme activities for prenatal diagnosis of respiratory chain deficiency. Prenat. Diagn. 20, 732-737.
59. Honzik, T., Wenchich, L., Bohm, M., Hansikova, H., Pejznochova, M., Zapadlo, M., Plavka, R., and Zeman, J. (2008) Activities of respiratory chain complexes and pyruvate dehydrogenase in isolated muscle mitochondria in premature neonates. Early Hum. Dev. 84, 269-276.
60. Wallace, D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
61. Oey, N. A., van Vlies, N., Wijburg, F. A., Wanders, R. J., Attie-Bitach, T., and Vaz, F. M. (2006) L-carnitine is synthesized in the human fetalplacental unit: potential roles in placental and fetal metabolism. Placenta 27, 841-846.
62. Berger, P. S. and Wood, P. A. (2004) Disrupted blastocoele formation reveals a critical developmental role for long-chain acyl-CoA dehydrogenase. Mol. Genet. Metab. 82, 266-272.
63. Lundy, C. T., Shield, J. P., Kvittingen, E. A., Vinorum, O. J., Trimble, E. R., and Morris, A. A. (2003) Acute respiratory distress syndrome in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies. J. Inherit. Metab. Dis. 26, 537-541.
64. den Boer, M. E., Wanders, R. J., Morris, A. A., L, I. J., Heymans, H. S., and Wijburg, F. A. (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109, 99-104.
65. Ibdah, J. A., Paul, H., Zhao, Y., Binford, S., Salleng, K., Cline, M., Matern, D., Bennett, M. J., Rinaldo, P., and Strauss, A. W. (2001) Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107, 1403-1409.
66. Tyni, T., Ekholm, E., and Pihko, H. (1998) Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am. J. Obstet. Gynecol. 178, 603-608.
67. Lane, R. H., Maclennan, N. K., Daood, M. J., Hsu, J. L., Janke, S. M., Pham, T. D., Puri, A. R., and Watchko, J. F. (2003) IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptorgamma coactivator-1 gene expression in a fiber specific manner. Pediatr. Res. 53, 994-1000.
68. Barker, D. J. (1998) In utero programming of chronic disease. Clin. Sci. (Lond.) 95, 115-128.
69. North, K. N., Hoppel, C. L., De Girolami, U., Kozakewich, H. P., and Korson, M. S. (1995) Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J. Pediatr. 127, 414-420.
70. Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., and Strauss, A. W. (1999) A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N. Engl. J. Med. 340, 1723-1731.
71. Strauss, A. W., Bennett, M. J., Rinaldo, P., Sims, H. F., O'Brien, L. K., Zhao, Y., Gibson, B., and Ibdah, J. (1999) Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin. Perinatol. 23, 100-112.
72. Schoeman, M. N., Batey, R. G., and Wilcken, B. (1991) Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 100, 544-548.
73. Illsinger, S., Janzen, N., Sander, S., Schmidt, K. H., Bednarczyk, J., Mallunat, L., Bode, J., Hagebolling, F., Hoy, L., Lucke, T., Hass, R., and Das, A. M. Preeclampsia and HELLP Syndrome: Impaired Mitochondrial Function in Umbilical Endothelial Cells. Reprod. Sci. 17, 219-226.
74. Wada, N., Matsuishi, T., Nonaka, M., Naito, E., and Yoshino, M. (2004) Pyruvate dehydrogenase E1alpha subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms. Brain Dev. 26, 57-60.
75. Robinson, B. H., MacKay, N., Chun, K., and Ling, M. (1996) Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J. Inherit. Metab. Dis. 19, 452-462.
76. Pithukpakorn, M. (2005) Disorders of pyruvate metabolism and the tricarboxylic acid cycle. Mol. Genet. Metab. 85, 243-246.
77. Brown, G. K., Otero, L. J., LeGris, M., and Brown, R. M. (1994) Pyruvate dehydrogenase deficiency. J. Med. Genet. 31, 875-879.
78. Rahman, S., Blok, R. B., Dahl, H. H., Danks, D. M., Kirby, D. M., Chow, C. W., Christodoulou, J., and Thorburn, D. R. (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann. Neurol. 39, 343-351.
79. Hansen, L. L., Brown, G. K., Kirby, D. M., and Dahl, H. H. (1991) Characterization of the mutations in three patients with pyruvate dehydrogenase E1 alpha deficiency. J Inherit Metab Dis 14, 140-151.
80. Cross, J. H., Connelly, A., Gadian, D. G., Kendall, B. E., Brown, G. K., Brown, R. M., and Leonard, J. V. (1994) Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr Neurol 10, 276-283.
81. Shevell, M. I., Matthews, P. M., Scriver, C. R., Brown, R. M., Otero, L. J., Legris, M., Brown, G. K., and Arnold, D. L. (1994) Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 11, 224-229.
82. Rubio-Gozalbo, M. E., Heerschap, A., Trijbels, J. M., De Meirleir, L., Thijssen, H. O., and Smeitink, J. A. (1999) Proton MR spectroscopy in a child with pyruvate dehydrogenase complex deficiency. Magn Reson Imaging 17, 939-944.
83. Harada, M., Tanouchi, M., Arai, K., Nishitani, H., Miyoshi, H., and Hashimoto, T. (1996) Therapeutic efficacy of a case of pyruvate dehydrogenase complex deficiency monitored by localized proton magnetic resonance spectroscopy. Magn Reson Imaging 14, 129-133.
84. Zand, D. J., Simon, E. M., Pulitzer, S. B., Wang, D. J., Wang, Z. J., Rorke, L. B., Palmieri, M., and Berry, G. T. (2003) In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. AJNR Am J Neuroradiol 24, 1471-1474.
85. Munnich, A. and Rustin, P. (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106, 4-17.
86. Munnich, A., Rustin, P., Rotig, A., Chretien, D., Bonnefont, J. P., Nuttin, C., Cormier, V., Vassault, A., Parvy, P., Bardet, J., and et al. (1992) Clinical aspects of mitochondrial disorders. J Inherit Metab Dis 15, 448-455.
87. Gibson, K., Halliday, J. L., Kirby, D. M., Yaplito-Lee, J., Thorburn, D. R., and Boneh, A. (2008) Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses. Pediatrics 122, 1003-1008.
88. von Kleist-Retzow, J. C., Cormier-Daire, V., Viot, G., Goldenberg, A., Mardach, B., Amiel, J., Saada, P., Dumez, Y., Brunelle, F., Saudubray, J. M., Chretien, D., Rotig, A., Rustin, P., Munnich, A., and De Lonlay, P. (2003) Antenatal manifestations of mitochondrial respiratory chain deficiency. J. Pediatr. 143, 208-212. (Pubitemid 37082953)
89. Wenchich, L., Zeman, J., Hansikova, H., Plavka, R., Sperl, W., and Houstek, J. (2002) Mitochondrial energy metabolism in very premature neonates. Biol. Neonate. 81, 229-235.
90. Marin-Garcia, J., Ananthakrishnan, R., and Goldenthal, M. J. (2000) Heart mitochondrial DNA and enzyme changes during early human development. Mol. Cell Biochem. 210, 47-52.
91. Minai, L., Martinovic, J., Chretien, D., Dumez, F., Razavi, F., Munnich, A., and Rotig, A. (2008) Mitochondrial respiratory chain complex as sembly and function during human fetal development. Mol. Genet. Metab. 94, 120-126.
92. Alcolea, M. P., Colom, B., Llado, I., Garcia-Palmer, F. J., and Gianotti, M. (2007) Mitochondrial differentiation and oxidative phosphorylation system capacity in rat embryo during placentation period. Reproduction 134, 147-154.
93. Papa, S. (1996) Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim. Biophys. Acta. 1276, 87-105.
94. Izquierdo, J. M., Luis, A. M., and Cuezva, J. M. (1990) Postnatal mitochondrial differentiation in rat liver. Regulation by thyroid hormones of the beta-subunit of the mitochondrial F1-ATPase complex. J. Biol. Chem. 265, 9090-9097.
95. Kim, K., Lecordier, A., and Bowman, L. H. (1995) Both nuclear and mitochondrial cytochrome c oxidase mRNA levels increase dramatically during mouse postnatal development. Biochem. J. 306(Pt 2), 353-358.
96. Capaldi, R. A. (1988) Mitochondrial myopathies and respiratory chain proteins. Trends Biochem. Sci. 13, 144-148.
97. Zeviani, M., Peterson, P., Servidei, S., Bonilla, E., and DiMauro, S. (1987) Benign reversible muscle cytochrome c oxidase deficiency: a second case. Neurology 37, 64-67.
98. Low, E., Crushell, E. B., Harty, S. B., Ryan, S. P., and Treacy, E. P. (2008) Reversible multiorgan system involvement in a neonate with complex IV deficiency. Pediatr. Neurol. 39, 368-370.
99. Engelmann, G., Meyburg, J., Shahbek, N., Al-Ali, M., Hairetis, M. H., Baker, A. J., Rodenburg, R. J., Wenning, D., Flechtenmacher, C., Ellard, S., Smeitink, J. A., Hoffmann, G. F., and Buchanan, C. R. (2008) Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J. Inherit. Metab. Dis. 31, 540-546.